Trial Profile
Immunotherapy of Natural Killer in HTLV-1 Associated Myelopathy
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Nov 2018
Price :
$35
*
At a glance
- Drugs Natural killer cell therapy (Primary)
- Indications Spinal cord disorders
- Focus Therapeutic Use
- 18 Nov 2016 New trial record